Skip to main content
. 2023 Aug 31;15(9):2257. doi: 10.3390/pharmaceutics15092257
PDT photodynamic therapy
ROS reactive oxygen species
CSC cancer stem cell
FDA Food and Drug Administration
Ce6 chlorin e6
PTT photothermal therapy
DAMP damage-associated molecular pattern
COF composite-type optical fiberscope
CELC central early stage lung cancer
AuNP gold nanoparticle
Ab antibody
VEGF vascular endothelial growth factor
HPPH 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a
CIS carcinomas in situ
MIC microinvasive cancer
SCC squamous cell carcinoma
mTHPC m-tetrahydroxyphenylchlorin
EMA European Medicines Agency
HPR N-(4-hydroxyphenyl) retinamide
QOL quality of life
EGFR epidermal growth factor receptor
TPCS2a disulfonated tetraphenyl chlorine
BCC basal-cell carcinoma
5-ALA 5-aminolevulinic acid
AK actinic keratosis
MAL methyl aminolevulinate
EGCG epigallocatechin gallate
MHRF Ministry of Health of the Russian Federation
PpIX protoporphyrin IX
ABCG2 ATP-binding cassette transporter subfamily G2
PSA prostate-specific antigen
VTP vascular-targeted PDT
SOF supramolecular organic framework
MHLW Ministry of Health, Labor and Welfare
TNBC triple-negative breast cancer
BN bifunctional theranostic nanoprobe
SNNB sentinel node navigation biopsy
MTD maximum tolerated dose
CLIPT continuous low-irradiance PDT
Bcl-2 B-cell lymphoma 2
DFFA DNA fragmentation factor alpha
CASP2 caspase 2